The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2022 | Is cure possible in multiple myeloma?
In this video, Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, shares his opinion on the possibility of achieving cure in multiple myeloma. Prof. Mohty explains that cure needs to be clearly defined for different patient subgroups, and further compares approaches to achieving cure in elderly patients versus younger patients, highlighting the importance of sustained measurable residual disease (MRD) negativity in this process. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
